Skip to content
AI × 生物医药评分44

OpenMTB-Audit: Exposing Over-Refusal and Clinical Expert Perspectives in LLM-Based Molecular Tumor Board Safety Evaluation

Original articleChinese edition

No English body on site. Use the original article link above.